Velorum Therapeutics
ActiveBreakthrough medicines unlocking the biology of heme
About
Velorum Therapeutics is developing breakthrough medicines by unlocking the biology of heme.
Founders · 2
Co-Founder & CEO @ Velorum Therapeutics. Building new medicines.
Co-Founder and President @ Velorum Therapeutics. Goldwater Scholar. Working to create breakthrough medicines for devastating diseases.
Launch
We're developing a new class of cancer drugs that starve tumors by hijacking cancer metabolism.
Velorum Therapeutics develops a new class of cancer drugs that starve tumors by removing heme, a molecule cancers rely on for energy. They report mouse data and plan first-in-human trials next year, starting with lung cancer, with potential applicability to other cancers.
From the original launch (Feb 2024) — may be outdated.
Related startups
Elevated mRNA for transformative medicines.
Our drugs engage the immune system to fight tumors
